David P. Meeker, President and CEO at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 19,792 shares at $57.22 ($1.1M) on 2025-02-19, disclosed to the SEC on 2025-02-19.
Scheduled sale ($1.1M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.22 | 9,896 | $566K | 50.0% |
| 2 | $57.22 | 9,896 | $566K | 50.0% |
| Total | $57.22 avg | 19,792 | $1.1M | 100% |
| Filing → |
| RYTM | SELL | 2025-02-04 | $508K | — | Filing → |
| TRVI | SELL | 2024-08-29 | $13K | — | Filing → |
| RYTM | SELL | 2024-03-19 | $3.6M | — | Filing → |